An analytical biomarker for treatment of patients with recurrent B-ALL after remission induced by infusion of anti-CD19 chimeric antigen receptor T (CAR-T) cells. [electronic resource]
Producer: 20170111Description: 379-85 p. digitalISSN:- 1869-1889
- Adult
- Antigens, CD19 -- genetics
- Biomarkers, Tumor -- analysis
- C-Reactive Protein -- immunology
- Clinical Trials, Phase I as Topic
- Female
- Humans
- Immunotherapy, Adoptive -- methods
- Interferon-gamma -- blood
- Interleukin-10 -- blood
- Interleukin-6 -- blood
- Male
- Middle Aged
- Neoplasm Recurrence, Local
- Precursor B-Cell Lymphoblastic Leukemia-Lymphoma -- immunology
- Receptors, Antigen, T-Cell -- genetics
- Recombinant Fusion Proteins -- genetics
- Remission Induction
- T-Lymphocytes -- immunology
- Treatment Outcome
No physical items for this record
Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.